Online Interviews

Immunoglobulin Treatment Experiences for HCPs

This study explores current experiences and perspectives around the use of immunoglobulin (Ig) therapies in clinical practice. We’re looking for immunologists, immunology specialist nurses, and hospital pharmacists working in immunology to better understand real-world practices, challenges, and decision-making approaches related to Ig treatment. 
The insights gathered will help inform future developments and support resources for healthcare professionals involved in Ig therapy.

  • Location: Nationwide, United Kingdom
  • Date: 26th November
  • Duration: 75 minutes + 10 min for the pre -task
  • Incentive: TBC (Up to £260)
JWW_HCP_Decision_Making_3rd_October_2025
Intravenous immunoglobulin (IVIg)
Intravenous immunoglobulin (IVIg)
Intravenous immunoglobulin (IVIg)
I am the key decision maker
Ordering Stock prescription medications for the hospital
Conventional subcutaneous immunoglobulin (cSCIg)
Conventional subcutaneous immunoglobulin (cSCIg)
Conventional subcutaneous immunoglobulin (cSCIg)
I am involved in the treatment decision making process.
Decisions regarding choice of Ig administration approach (eg IVIg vs cSCIg vs fSCIg)
First
Facilitated subcutaneous immunoglobulin (fSCIg)
Facilitated subcutaneous immunoglobulin (fSCIg)
Facilitated subcutaneous immunoglobulin (fSCIg)
I am not involved in the decision making process.
Ig formulary decision making
Last
Local Ig guideline development
What is your level of expertise?